Bausch Health Company Insiders
BHC Stock | USD 7.16 0.03 0.42% |
Bausch Health employs about 20.7 K people. The company is managed by 39 executives with a total tenure of roughly 162 years, averaging almost 4.0 years of service per executive, having 530.77 employees per reported executive. Evaluation of Bausch Health's management performance can provide insight into the firm performance.
William Humphries Chairman Executive Vice President Company Group Chairman, Dermatology |
Joseph Papa Chairman Chairman of the Board, Chief Executive Officer |
Bausch |
Bausch Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Bausch Health's future performance. Based on our forecasts, it is anticipated that Bausch will maintain a workforce of about 20700 employees by April 2025.Bausch Health Management Team Effectiveness
The company has Return on Asset of 0.0433 % which means that on every $100 spent on assets, it made $0.0433 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (23.0454) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.10, whereas Return On Tangible Assets are projected to grow to (0). At present, Bausch Health's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 5.8 B, whereas Total Assets are forecasted to decline to about 15.4 B.As of March 24, 2025, Common Stock Shares Outstanding is expected to decline to about 251.3 M. In addition to that, Net Loss is expected to decline to about (212.6 M)
Bausch Health Workforce Comparison
Bausch Health Companies is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 176,352. Bausch Health retains roughly 20,700 in number of employees claiming about 12% of equities under Health Care industry.
Bausch Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bausch Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.5 | 3 | 2 | 12,715 | 2,132 |
2024-09-01 | 1.5 | 6 | 4 | 505,004 | 83,372 |
2024-06-01 | 12.0 | 12 | 1 | 332,945 | 1,930 |
2024-03-01 | 0.5385 | 7 | 13 | 718,594 | 150,726 |
2023-12-01 | 1.0 | 4 | 4 | 16,676 | 2,288 |
2023-09-01 | 0.8 | 4 | 5 | 16,269 | 120,063 |
2023-06-01 | 13.0 | 13 | 1 | 279,562 | 1,929 |
2023-03-01 | 0.5714 | 12 | 21 | 1,033,324 | 59,123 |
2022-12-01 | 3.0 | 6 | 2 | 30,883 | 2,025 |
2022-09-01 | 11.0 | 11 | 1 | 734,670 | 15,389 |
2022-06-01 | 1.7647 | 30 | 17 | 929,265 | 763,516 |
2022-03-01 | 0.5227 | 23 | 44 | 1,460,990 | 558,448 |
2021-12-01 | 4.5 | 9 | 2 | 67,447 | 3,744 |
2021-09-01 | 3.0 | 12 | 4 | 238,491 | 14,854 |
2021-06-01 | 2.0 | 22 | 11 | 374,876 | 317,105 |
2021-03-01 | 1.619 | 34 | 21 | 1,377,114 | 807,889 |
2020-12-01 | 1.0 | 7 | 7 | 42,000 | 76,832 |
2020-09-01 | 0.8333 | 5 | 6 | 35,127 | 21,892 |
2020-06-01 | 3.375 | 27 | 8 | 6,064,443 | 1,172,387 |
2020-03-01 | 1.1667 | 35 | 30 | 1,320,046 | 254,338 |
2019-12-01 | 4.0 | 4 | 1 | 4,281 | 3,337 |
2019-09-01 | 1.0 | 8 | 8 | 118,516 | 65,682 |
2019-06-01 | 2.0 | 14 | 7 | 111,408 | 129,154 |
2019-03-01 | 1.6923 | 22 | 13 | 944,388 | 62,273 |
2018-12-01 | 2.3333 | 7 | 3 | 63,817 | 19,946 |
2018-09-01 | 0.5294 | 9 | 17 | 209,965 | 234,592 |
2018-06-01 | 6.0 | 24 | 4 | 283,978 | 105,400 |
2018-03-01 | 3.8333 | 23 | 6 | 8,656,748 | 7,089,655 |
2017-12-01 | 6.0 | 6 | 1 | 360,349 | 344,216 |
2017-09-01 | 1.5 | 6 | 4 | 18,836 | 1,003,273 |
2017-06-01 | 2.3333 | 14 | 6 | 254,703 | 20,408 |
2017-03-01 | 20.0 | 20 | 1 | 645,182 | 0.00 |
2016-12-01 | 0.8333 | 5 | 6 | 9,130,508 | 3,524,643 |
2016-09-01 | 1.1667 | 7 | 6 | 183,948 | 24,582 |
2016-06-01 | 2.4 | 24 | 10 | 12,778,244 | 18,240,000 |
2016-03-01 | 0.1429 | 1 | 7 | 1,096 | 57,408 |
2015-12-01 | 1.5 | 9 | 6 | 14,227 | 1,314,057 |
2015-06-01 | 1.0357 | 29 | 28 | 424,183 | 4,843,370 |
2015-03-01 | 0.9167 | 11 | 12 | 712,680 | 310,412 |
2014-12-01 | 1.3636 | 15 | 11 | 681,876 | 141,674 |
2014-09-01 | 1.0 | 4 | 4 | 18,810 | 30,119 |
Bausch Health Notable Stakeholders
A Bausch Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bausch Health often face trade-offs trying to please all of them. Bausch Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bausch Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
William Humphries | Executive Vice President Company Group Chairman, Dermatology | Profile | |
Joseph Papa | Chairman of the Board, Chief Executive Officer | Profile | |
Thomas Appio | Executive Vice President Company Group Chairman, International | Profile | |
Paul Herendeen | Chief Financial Officer, Executive Vice President | Profile | |
Joseph Gordon | President and Co-Head Bausch + Lomb/International | Profile | |
Christina Ackermann | Executive Vice President, General Counsel and Head of Commercial Operations | Profile | |
Mirza Dautbegovic | Executive COO | Profile | |
Sarah Kavanagh | Independent Director | Profile | |
Richard Schutter | Independent Director | Profile | |
Amy Wechsler | Independent Director | Profile | |
Robert Power | Independent Director | Profile | |
Argeris Karabelas | Independent Director | Profile | |
Thomas Ross | Lead Independent Director | Profile | |
Andrew Eschenbach | Independent Director | Profile | |
John Paulson | Independent Director | Profile | |
Russel Robertson | Independent Director | Profile | |
John Barresi | Controller, VP | Profile | |
Garen Sarafian | VP Relations | Profile | |
MSc MD | Chief VP | Profile | |
D Hale | Independent Director | Profile | |
Jeff Hartness | Commercial Access | Profile | |
Arthur Shannon | IR Contact Officer | Profile | |
Tage MD | Chief RD | Profile | |
Robert Butz | VP Affairs | Profile | |
Brett Icahn | Independent Director | Profile | |
Seana Carson | Executive Counsel | Profile | |
Josh Coyle | Senior Salix | Profile | |
Graham Jackson | Senior Officer | Profile | |
Sam Will | Senior Vice President - Finance, Chief Accounting Officer, Controller | Profile | |
Thomas Vadaketh | Ex CFO | Profile | |
Kathleen Fitzpatrick | Executive Officer | Profile | |
Jiny MBA | Senior Medical | Profile | |
William Woodfield | Senior Treasurer | Profile | |
Donald Pearl | Senior Dermatologics | Profile | |
JeanJacques Charhon | Chief Officer | Profile | |
Aimee Lenar | Executive Pharma | Profile | |
Steven Miller | Independent Director | Profile | |
Robert Spurr | President - Salix | Profile | |
Cees Heiman | Senior Canada | Profile |
About Bausch Health Management Performance
The success or failure of an entity such as Bausch Health Companies often depends on how effective the management is. Bausch Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bausch management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bausch management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Capital Employed | 0.08 | 0.10 | |
Return On Equity | 0.04 | 0.03 |
Please note, the presentation of Bausch Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bausch Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bausch Health's management manipulating its earnings.
Bausch Health Workforce Analysis
Traditionally, organizations such as Bausch Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bausch Health within its industry.Bausch Health Manpower Efficiency
Return on Bausch Health Manpower
Revenue Per Employee | 459.8K | |
Revenue Per Executive | 244.1M | |
Net Loss Per Employee | 3.5K | |
Net Loss Per Executive | 1.8M |
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |